ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/05/2024
Back to search
Official data from USPTO
NEXTBIOPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEXTBIOPHARM
ST13
US500000090106738Class
9, 35, 38, 42, 44, 45
Filing
90106738
Registration
6986937
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
09/05/2024
Trademark type
Word
Nice classes
9, 35, 38, 42, 44, 45
Filing date
08/11/2020
Registration date
02/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/21/2023
Last transaction
07/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/17/2022
First use in commerce
10/17/2022
Drawing code
4
Owner type
16
Owner location
SHANGHAI, CN
Examiner
WLODARCZYK, CAROLYN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHARMCUBE GROUP CO., LTD.
PHARMCUBE (BEIJING) CO., LTD.
Representatives
John R. Hlavka WATTS LAW LLC
Technical classification
Nice Classes
Class 9Class 35Class 38Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic datadownloadable electronic data files featuring pharmaceuticalmedicalhealthcarelife science information
Class 35
Providing clients with business consultingcompetitive product researchclinical data analysismarket analysisproduct line evaluation planning through an online searchable databasebusiness consulting and marketing research and analysis services in the fields of pharmaceuticalsmedicineshealthcare and life science; Conducting market researchdata statistics and information analysis and providing industry research perspectives via an online searchable computer databaseanalyzing and compiling business data and market research in the fields of pharmaceuticalmedicalhealthcarelife science by means of an online searchable computer database for business purposes; Providing an online searchable database providing business intelligence in the fields of pharmaceuticalsmedicineshealthcare and life science
Class 38
Providing access to databases; Providing electronic transmission of data and documentssending information and images in the nature of telematics sending of information relating to pharmaceuticalsmedicineshealthcare via computer terminals
Class 42
Implementing early assessment for new drugsproviding an online searchable database featuring information regarding new drugs in the nature of drug discovery services for scientific research purposes; Consulting services in the field of technology developmentconsulting services in the field of technology development in the fields of pharmaceuticalsmedicineshealthcare and life science; Providing search enginesproviding search engines for obtaining data from the internet; Providing an online searchable database featuring information regarding pharmaceuticalsmedicineshealthcare and life science for scientific research purposes; File sharing servicesproviding a website featuring technology enabling users to download electronic files of patent documents
Class 44
Providing an online searchable database featuring information regarding pharmaceuticalsmedicineshealthcare for medical purposes
Class 45
Providing information relating to pharmaceutical patentsproviding an online searchable computer database featuring information regarding patents and patent applications in the fields of pharmaceuticalsmedicineshealthcare and life science; Providing patent search servicesproviding an online searchable database featuring information regarding patents and patent applications in the fields of pharmaceuticalsmedicineshealthcare and life science
Publications
History of USPTO decisions and trademark events.
39 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/19/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/30/2022
EX1G
SOU EXTENSION 1 GRANTED
11/30/2022
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
11/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2022
INCE
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
11/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/27/2022
IUAF
USE AMENDMENT FILED
10/18/2022
EXT1
SOU EXTENSION 1 FILED
10/18/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/18/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/18/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/22/2022
PUBO
PUBLISHED FOR OPPOSITION
02/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/17/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/18/2021
GNFR
FINAL REFUSAL E-MAILED
07/18/2021
CNFR
FINAL REFUSAL WRITTEN
07/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2020
GNRT
NON-FINAL ACTION E-MAILED
12/05/2020
CNRT
NON-FINAL ACTION WRITTEN
12/05/2020
DOCK
ASSIGNED TO EXAMINER
12/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2020
NWAP
NEW APPLICATION ENTERED
08/14/2020
Continuous trademark protection
Get notified about every new filing that threatens NEXTBIOPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.